Abstract:T-cell immunodeficiency is a common feature in patients with leukemia, lower activation of T cells was one of reasons. The TCR zeta chain has emerged as a key subunit of the T-cell antigen receptor, which plays a central role in the signal-transducing events leading to T cell activation. The proliferation and activation of T cells may be inducted by T cell related cytokines. In this study, we explored the change of TCR zeta gene expression and the clonality of T cells after induction with different immune cytokines, including IL-2, IL-7 or IL-12. CD3+ T cells sorted from peripheral blood of 4 cases with AML were induced with different immune cytokines, including IL-2, IL-7, IL-12, anti-CD3 and anti-CD28 antibodies in vitro. The expression levels of TCR zeta gene and related genes in T cells before and after induction were then analyzed by fluorescence quantitative RT-PCR. The distribution and clonality of TCR Vβ subfamily T cells were analyzed by RT-PCR and Genescan techniques. Increasing expression levels of TCR zeta gene and zap-70 (TCR zeta chain associated-protein) gene in CD3+T cells from AML patients were found after induction with single stimulating factor or the combination with different cytokines, while the expression of FceRIγ (TCR ζ gene complementary factor) was down-regulated. We further compared the T cell clonality in CD3+T cells from AML patients after cytokine induction, eight to 22 TCR V β subfamilies could be detected in T cells from AML cases, most of them displayed polyclonal expansion. The number of expressed TCR Vβ subfamilies was increased without the change of clonality in T cells induced by CD3+CD28+IL7. In conclusion, TCR zeta gene and its related genes could be upregulated through induction with different cytokine combination such as IL-2, IL-7 and IL-12, therefore to improve the T cell activation in patients with AML. And the main effect of cytokines might to maintain the T cell clonality and nonspecific amplification of T cell clones. Further investigation can be designed to amplify the specific anti-AML TCR Vβ clones using AML associated antigens and such cytokine combination. Disclosures Shi:National Natural Science Foundation of China (no. 81100353, 81270604), the Fundamental Research Funds for the Central Universities (No. 21611447, 21612116), And Medical Science Foundation of Guangdong Province(A2011325). : Research Funding.

Cc Chemokine Ligand 25 Enhances Resistance To Apoptosis In Cd4(+) T Cells From Patients With T-Cell Lineage Acute And Chronic Lymphocytic Leukemia By Means Of Livin Activation

Retraction Note: Selectively Frequent Expression of CXCR5 Enhances Resistance to Apoptosis in CD8+CD34+ T Cells from Patients with T-cell-lineage Acute Lymphocytic Leukemia

CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.

Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-cell Lineage Acute Lymphocytic Leukemia.

Peg10 Activation by Co-Stimulation of Cxcr5 and Ccr7 Essentially Contributes to Resistance to Apoptosis in Cd19(+)Cd34(+) B Cells from Patients with B Cell Lineage Acute and Chronic Lymphocytic Leukemia

Specific Killing of CCR9 High-Expressing Acute T Lymphocytic Leukemia Cells by CCL25 Fused with PE38 Toxin

CCL25 Promotes the Migration and Invasion of Non-Small Cell Lung Cancer Cells by Regulating VEGF and MMPs in a CCR9-dependent Manner.

Wnt5a and CCL25 Promote Adult T-cell Acute Lymphoblastic Leukemia Cell Migration, Invasion and Metastasis

Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice.

CCR9–CCL25 Interaction Suppresses Apoptosis of Lung Cancer Cells by Activating the PI3K/Akt Pathway

Analysis of the Expression Pattern of the BCL11B Gene and Its Relatives in Patients with T-cell Acute Lymphoblastic Leukemia

Intratumoral Delivery of CCL25 Enhances Immunotherapy Against Triple-Negative Breast Cancer by Recruiting CCR9+ T Cells

CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma.

Bcl-xl is associated with the anti-apoptotic effects of IL-15 on CD4~+CD25~+ regulatory T cells

Sensitivity of T-cell Acute Lymphoblastic Leukemia to TRAIL Induced Apoptosis

Increased Population of CD4(+)CD25(high), Regulatory T Cells with Their Higher Apoptotic and Proliferating Status in Peripheral Blood of Acute Myeloid Leukemia Patients.

MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells

Developing and Activated T Cell Survival Depends on Differential Signaling Pathways to Regulate Anti-Apoptotic Bcl-x(L).

Soluble CXCL16 Promotes TNF‐α‐induced Apoptosis in DLBCL Via the AMAD10‐NF‐κB Regulatory Feedback Loop

Increasing TCR Zeta Expression and Maintaining the Clonality of T Cells from AML Patients after IL-2, IL-7 and IL-12 Induction

Akt-Mediated Eminent Expression of C-Flip and Mcl-1 Confers Acquired Resistance to Trail-Induced Cytotoxicity to Lung Cancer Cells